多模式干预方案的有效性,以预防胃肠道手术后重症老年患者的压力
Hai-Ming Xi1, Man-Li Tian2, Ya-Li Tian1
1Geriatric ICU, Jiangsu Province Hospital, Nanjing 210029, Jiangsu Province, China.
World journal of gastrointestinal surgery
|April 28, 2025
概括
一项新的多模式干预措施显著减少了胃肠道手术后老年ICU患者的压力. 这种方案改善了这个高风险群体的愈合时间,降低了并发症,并缩短了住院时间.
科学领域:
- 关键护理医学 关键护理医学
- 胃肠病学 胃肠病学
- 老年医学 老年医学
背景情况:
- 压力是重症患者的常见并发症,特别是胃肠道手术后的老年人.
- 在重症监护室 (ICU) 接受胃肠道手术的老年患者面临更高的发展压力的风险.
研究的目的:
- 评估一个多模式的干预方案,以预防老年ICU患者的压力术后.
- 评估这种干预对压力发病率和相关临床结果的影响.
主要方法:
- 进行了一项随机对照试验,对200名患有严重疾病的患者 (≥65岁) 进行了胃肠道手术.
- 患者被分配到多模式压力预防方案或标准护理.
- 主要结局是压力发病率;次要结局包括愈合时间,并发症和住院.
主要成果:
- 干预组的压力发病率显著降低 (15%对30%,P<0.01).
- 在干预组中观察到愈的速度更快 (5.2 vs. 7.8天,P < 0.05),并发症更少 (10% vs. 22%,P < 0.05),住院时间更短 (12.3 vs. 15.7天,P < 0.05).
结论:
- 多模式干预有效地减少了高风险老年患者的压力发病率.
- 这种全面的协议改善了关键的临床结果,为重症监护机构提供了有价值的策略.
相关概念视频
Peptic Ulcer Disease IV: Management
45
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
45
Peptic Ulcer Disease V: Surgical Management and Nursing Care
153
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
153
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
298
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
298
Inflammatory Bowel Disease V: Surgical Management
57
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
57
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
319
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
319
Irritable Bowel Syndrome III: Medical and Nursing Management
113
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
113


